SCHEMBL23861597

SCHEMBL23861597

CC(Cc1cccc2ccccc12)(c1ccc(O)c(-c2ccccc2)c1)c1ccc(O)c(-c2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 1/20 0.45
▸ HSD17B2 P37059 1/20 0.45
▸ ESR1 P03372 1/20 0.41
▸ ESR2 Q92731 1/20 0.41
▸ CHRNB2 P17787 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ BACE1 P56817 2/20 0.39
▸ NR1I2 O75469 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ SIGMAR1 Q99720 1/20 0.39
▸ CASR P41180 1/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ HPGD P15428 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861595 0.88 CYP2D6 (0.39) NR1I2LMNAADRA2ACYP2D6ACHE
SCHEMBL23861523 0.80 BACE1 (0.43) HSD17B1HSD17B2ESR1ESR2BACE1
SCHEMBL23861369 0.79 MEN1 (0.46) ESR1ESR2NR1I2LMNAADRA2A
SCHEMBL8956985 0.77 BACE1 (0.48) HSD17B1HSD17B2ESR1ESR2BACE1
SCHEMBL23861520 0.76 CNR1 (0.48) HSD17B1HSD17B2ESR1ESR2BACE1
SCHEMBL9817011 0.75 BACE1 (0.46) HSD17B1HSD17B2ESR1ESR2BACE1
SCHEMBL22051848 0.74 CYP2D6 (0.46) NR1I2LMNAADRA2ACYP2D6ACHE
SCHEMBL22051843 0.74 CYP2D6 (0.41) ESR1ESR2NR1I2LMNAADRA2A
SCHEMBL22051112 0.74 CYP3A4 (0.44) NR1I2LMNAADRA2ACYP2D6ACHE
SCHEMBL23861384 0.74 HPGD (0.48) HSD17B1HSD17B2ESR1ESR2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 HSD17B1 1116/4885HSD17B2 1269/4885ESR1 713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback